CLOs on the Move

Charlottesville Medical Research

www.cvillemedresearch.com

 
Charlottesville Medical Research is a Charlottesville, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

dbMotion

dbMotion is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Pittsburgh, PA. To find more information about dbMotion, please visit www.dbmotion.com

HealthSTAR Communications, Inc.

HealthSTAR Communications, Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.

ProviderLink

ProviderLink is a Cary, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Austen Riggs Center

Austen Riggs Center is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in West Stockbridge, MA. To find more information about Austen Riggs Center, please visit www.austenriggs.net

Relmada

Relmada Therapeutics (OTCQB: RLMD) is a clinical-stage, publicly traded specialty pharmaceutical company developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of chronic pain. Relmada has a diversified portfolio of four lead products at various stages of development including d-Methadone (REL-1017) its N-methyl-D-aspartate (NMDA) receptor antagonist for neuropathic pain; topical mepivacaine (REL-1021), its orphan drug designated topical formulation of the local anesthetic mepivacaine; oral buprenorphine (REL-1028) its oral dosage form of the opioid analgesic buprenorphine; and LevoCap ER (REL-1015), its abuse resistant, sustained release dosage form of the opioid analgesic levorphanol. Relmada`s product development efforts are guided by the internationally recognized scientific expertise of our research team. Relmada`s approach is expected to reduce clinical development risks and costs while potentially delivering valuable products in areas of high unmet medical needs.